| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.65B | +7.3% |
| Cost of Revenue | $13.37B | +0.3% |
| Gross Profit | $27.28B | +11.1% |
| R&D Expense | $756.0M | -0.4% |
| Operating Income | $14.89B | +11.1% |
| Pre-tax Income | $13.88B | +13.8% |
| Income Tax | $2.74B | -9.3% |
| Net Income | $11.35B | +60.8% |
| EPS (Basic) | $7.27 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.87B | +15.6% |
| Accounts Receivable | $4.57B | +20.7% |
| Inventory | $11.48B | +21.4% |
| Current Assets | $24.36B | +20.8% |
| Total Assets | $69.19B | +12.0% |
| Current Liabilities | $25.43B | +11.0% |
| Long-term Debt | $45.13B | +7.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.23B | +0.1% |
| Capital Expenditures | $1.57B | +8.7% |
| Investing Cash Flow | -$3.97B | -263.3% |
| Financing Cash Flow | -$8.13B | +14.2% |
| Free Cash Flow | $10.66B | -1.0% |
| +60.5% |
| EPS (Diluted) | $7.26 | +60.6% |
| Total Liabilities |
| $77.21B |
| +7.8% |
| Stockholders' Equity | -$9.99B | +14.9% |